A multicentre, international neoadjuvant (NA), randomized, double-blind phase III trial comparing fulvestrant to a combination of fulvestrant and palbociclib in patients with operable luminal breast cancer (SAFIA Trial)

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 30; p. v67
Main Authors Nabholtz, J-MA, Alsaleh, K.A., Bounedjar, A., Oukkal, M., El-Zawahry, H.M., Bouzid, K., Razek, H Abdel, Mahfouf, H., Bensalem, A., Saadeddin, A., Filali, T., Larbaoui, B., Abulkhair, O., Al-Foheidi, M., Boussen, H., ayari, J., Ghosn, M., Abdel-Aziz, N., Dabouz, F., Kullab, S.
Format Journal Article
LanguageEnglish
Published 01.10.2019
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1093/annonc/mdz240.023